115 research outputs found
Evaluation of Cell Types for Assessment of Cytogenetic Damage in Arsenic Exposed Population
Background: Cytogenetic biomarkers are essential for assessing environmental exposure, and
reflect adverse human health effects such as cellular damage. Arsenic is a potential clastogen and
aneugen. In general, the majority of the studies on clastogenic effects of arsenic are based on
frequency of micronuclei (MN) study in peripheral lymphocytes, urothelial and oral epithelial cells.
To find out the most suitable cell type, here, we compared cytogenetic damage through MN assay
in (a) various populations exposed to arsenic through drinking water retrieved from literature
review, as also (b) arsenic-induced Bowen's patients from our own survey.
Results: For literature review, we have searched the Pubmed database for English language journal
articles using the following keywords: "arsenic", "micronuclei", "drinking water", and "human" in
various combinations. We have selected 13 studies consistent with our inclusion criteria that
measured micronuclei in either one or more of the above-mentioned three cell types, in human
samples. Compared to urothelial and buccal mucosa cells, the median effect sizes measured by the
difference between people with exposed and unexposed, lymphocyte based MN counts were found
to be stronger. This general pattern pooled from 10 studies was consistent with our own set of
three earlier studies. MN counts were also found to be stronger for lymphocytes even in arsenicinduced
Bowen's patients (cases) compared to control individuals having arsenic-induced noncancerous
skin lesions.
Conclusion: Overall, it can be concluded that MN in lymphocytes may be superior to other
epithelial cells for studying arsenic-induced cytogenetic damage
Genetic Variants Associated with Arsenic Susceptibility: Study of Purine Nucleoside Phosphorylase, Arsenic (+3) Methyltransferase, and Glutathione S-Transferase Omega Genes
BACKGROUND: Individual variability in arsenic metabolism may underlie individual susceptibility
toward arsenic-induced skin lesions and skin cancer. Metabolism of arsenic proceeds through
sequential reduction and oxidative methylation being mediated by the following genes: purine
nucleoside phosphorylase (PNP), arsenic (+3) methyltransferase (As3MT), glutathione S-transferase
omega 1 (GSTO1), and omega 2 (GSTO2). PNP functions as arsenate reductase; As3MT methylates
inorganic arsenic and its metabolites; and both GSTO1 and GSTO2 reduce the metabolites.
Alteration in functions of these gene products may lead to arsenic-specific disease manifestations.
OBJECTIVES: To find any probable association between arsenicism and the exonic single nucleotide
polymorphisms (SNPs) of the above-mentioned arsenic-metabolizing genes, we screened all the
exons in those genes in an arsenic-exposed population.
METHODS: Using polymerase chain reaction restriction fragment length polymorphism analysis, we
screened the exons in 25 cases (individuals with arsenic-induced skin lesions) and 25 controls (individuals
without arsenic-induced skin lesions), both groups drinking similar arsenic-contaminated
water. The exonic SNPs identified were further genotyped in a total of 428 genetically unrelated
individuals (229 cases and 199 controls) for association study.
RESULTS: Among four candidate genes, PNP, As3MT, GSTO1, and GSTO2, we found that distribution
of three exonic polymorphisms, His20His, Gly51Ser, and Pro57Pro of PNP, was associated
with arsenicism. Genotypes having the minor alleles were significantly overrepresented in the case
group: odds ratio (OR) = 1.69 [95% confidence interval (CI), 1.08–2.66] for His20His; OR = 1.66
[95% CI, 1.04–2.64] for Gly51Ser; and OR = 1.67 [95% CI, 1.05–2.66] for Pro57Pro.
CONCLUSIONS: The results indicate that the three PNP variants render individuals susceptible
toward developing arsenic-induced skin lesions.
KEY WORDS: arsenic, As3MT, GSTO1, GSTO2, PNP, skin lesion, susceptibility. Environ Health
Perspect 116:501–505 (2008). doi:10.1289/ehp.10581 available via http://dx.doi.org/ [Online
14 January 2008
Constraints on Astro-unparticle Physics from SN 1987A
SN 1987A observations have been used to place constraints on the interactions
between standard model particles and unparticles. In this study we calculate
the energy loss from the supernovae core through scalar, pseudo scalar, vector,
pseudo vector unparticle emission from nuclear bremsstrahlung for degenerate
nuclear matter interacting through one pion exchange. In order to examine the
constraints on we considered the emission of scalar, pseudo
scalar, vector, pseudo vector and tensor through the pair annihilation process
. In addition we have re-examined other pair
annihilation processes. The most stringent bounds on the dimensionless coupling
constants for and are obtained from
nuclear bremsstrahlung process for the pseudo scalar and pseudo-vector
couplings and for
tensor interaction, the best limit on dimensionless coupling is obtained from
and we get .Comment: 12 pages, 2 postscript figure
Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo
In the continuing search for effective cancer treatments, we report the rational
engineering of a multifunctional nanoparticle that combines traditional
chemotherapy with cell targeting and anti-adhesion functionalities. Very late
antigen-4 (VLA-4) mediated adhesion of multiple myeloma (MM) cells to bone
marrow stroma confers MM cells with cell-adhesion-mediated drug resistance
(CAM-DR). In our design, we used micellar nanoparticles as dynamic
self-assembling scaffolds to present VLA-4-antagonist peptides and doxorubicin
(Dox) conjugates, simultaneously, to selectively target MM cells and to overcome
CAM-DR. Dox was conjugated to the nanoparticles through an acid-sensitive
hydrazone bond. VLA-4-antagonist peptides were conjugated via a multifaceted
synthetic procedure for generating precisely controlled number of targeting
functionalities. The nanoparticles were efficiently internalized by MM cells and
induced cytotoxicity. Mechanistic studies revealed that nanoparticles induced
DNA double-strand breaks and apoptosis in MM cells. Importantly, multifunctional
nanoparticles overcame CAM-DR, and were more efficacious than Dox when MM cells
were cultured on fibronectin-coated plates. Finally, in a MM xenograft model,
nanoparticles preferentially homed to MM tumors with ∼10 fold more drug
accumulation and demonstrated dramatic tumor growth inhibition with a reduced
overall systemic toxicity. Altogether, we demonstrate the disease driven
engineering of a nanoparticle-based drug delivery system, enabling the model of
an integrative approach in the treatment of MM
Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
HIV's ability to establish long-lived latent infection is mainly due to transcriptional silencing in resting memory T lymphocytes and other non dividing cells including monocytes. Despite an undetectable viral load in patients treated with potent antiretrovirals, current therapy is unable to purge the virus from these latent reservoirs. In order to broaden the inhibitory range and effectiveness of current antiretrovirals, the potential of bryostatin was investigated as an HIV inhibitor and latent activator. Bryostatin revealed antiviral activity against R5- and X4-tropic viruses in receptor independent and partly via transient decrease in CD4/CXCR4 expression. Further, bryostatin at low nanomolar concentrations robustly reactivated latent viral infection in monocytic and lymphocytic cells via activation of Protein Kinase C (PKC) -α and -δ, because PKC inhibitors rottlerin and GF109203X abrogated the bryostatin effect. Bryostatin specifically modulated novel PKC (nPKC) involving stress induced AMP Kinase (AMPK) inasmuch as an inhibitor of AMPK, compound C partially ablated the viral reactivation effect. Above all, bryostatin was non-toxic in vitro and was unable to provoke T-cell activation. The dual role of bryostatin on HIV life cycle may be a beneficial adjunct to the treatment of HIV especially by purging latent virus from different cellular reservoirs such as brain and lymphoid organs
Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission
Mitigation of SARS-CoV-2 transmission from international travel is a priority. We evaluated the effectiveness of travellers being required to quarantine for 14-days on return to England in Summer 2020. We identified 4,207 travel-related SARS-CoV-2 cases and their contacts, and identified 827 associated SARS-CoV-2 genomes. Overall, quarantine was associated with a lower rate of contacts, and the impact of quarantine was greatest in the 16–20 age-group. 186 SARS-CoV-2 genomes were sufficiently unique to identify travel-related clusters. Fewer genomically-linked cases were observed for index cases who returned from countries with quarantine requirement compared to countries with no quarantine requirement. This difference was explained by fewer importation events per identified genome for these cases, as opposed to fewer onward contacts per case. Overall, our study demonstrates that a 14-day quarantine period reduces, but does not completely eliminate, the onward transmission of imported cases, mainly by dissuading travel to countries with a quarantine requirement
Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission
AbstractUnderstanding SARS-CoV-2 transmission in higher education settings is important to limit spread between students, and into at-risk populations. In this study, we sequenced 482 SARS-CoV-2 isolates from the University of Cambridge from 5 October to 6 December 2020. We perform a detailed phylogenetic comparison with 972 isolates from the surrounding community, complemented with epidemiological and contact tracing data, to determine transmission dynamics. We observe limited viral introductions into the university; the majority of student cases were linked to a single genetic cluster, likely following social gatherings at a venue outside the university. We identify considerable onward transmission associated with student accommodation and courses; this was effectively contained using local infection control measures and following a national lockdown. Transmission clusters were largely segregated within the university or the community. Our study highlights key determinants of SARS-CoV-2 transmission and effective interventions in a higher education setting that will inform public health policy during pandemics.</jats:p
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
Background
The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in England. We aimed to investigate whether increases in the proportion of infections with this variant are associated with differences in symptoms or disease course, reinfection rates, or transmissibility.
Methods
We did an ecological study to examine the association between the regional proportion of infections with the SARS-CoV-2 B.1.1.7 variant and reported symptoms, disease course, rates of reinfection, and transmissibility. Data on types and duration of symptoms were obtained from longitudinal reports from users of the COVID Symptom Study app who reported a positive test for COVID-19 between Sept 28 and Dec 27, 2020 (during which the prevalence of B.1.1.7 increased most notably in parts of the UK). From this dataset, we also estimated the frequency of possible reinfection, defined as the presence of two reported positive tests separated by more than 90 days with a period of reporting no symptoms for more than 7 days before the second positive test. The proportion of SARS-CoV-2 infections with the B.1.1.7 variant across the UK was estimated with use of genomic data from the COVID-19 Genomics UK Consortium and data from Public Health England on spike-gene target failure (a non-specific indicator of the B.1.1.7 variant) in community cases in England. We used linear regression to examine the association between reported symptoms and proportion of B.1.1.7. We assessed the Spearman correlation between the proportion of B.1.1.7 cases and number of reinfections over time, and between the number of positive tests and reinfections. We estimated incidence for B.1.1.7 and previous variants, and compared the effective reproduction number, Rt, for the two incidence estimates.
Findings
From Sept 28 to Dec 27, 2020, positive COVID-19 tests were reported by 36 920 COVID Symptom Study app users whose region was known and who reported as healthy on app sign-up. We found no changes in reported symptoms or disease duration associated with B.1.1.7. For the same period, possible reinfections were identified in 249 (0·7% [95% CI 0·6–0·8]) of 36 509 app users who reported a positive swab test before Oct 1, 2020, but there was no evidence that the frequency of reinfections was higher for the B.1.1.7 variant than for pre-existing variants. Reinfection occurrences were more positively correlated with the overall regional rise in cases (Spearman correlation 0·56–0·69 for South East, London, and East of England) than with the regional increase in the proportion of infections with the B.1.1.7 variant (Spearman correlation 0·38–0·56 in the same regions), suggesting B.1.1.7 does not substantially alter the risk of reinfection. We found a multiplicative increase in the Rt of B.1.1.7 by a factor of 1·35 (95% CI 1·02–1·69) relative to pre-existing variants. However, Rt fell below 1 during regional and national lockdowns, even in regions with high proportions of infections with the B.1.1.7 variant.
Interpretation
The lack of change in symptoms identified in this study indicates that existing testing and surveillance infrastructure do not need to change specifically for the B.1.1.7 variant. In addition, given that there was no apparent increase in the reinfection rate, vaccines are likely to remain effective against the B.1.1.7 variant.
Funding
Zoe Global, Department of Health (UK), Wellcome Trust, Engineering and Physical Sciences Research Council (UK), National Institute for Health Research (UK), Medical Research Council (UK), Alzheimer's Society
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
Abstract
Background
Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres.
Methods
This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries.
Results
In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia.
Conclusion
This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries
- …